000 | 01924 a2200529 4500 | ||
---|---|---|---|
005 | 20250517001612.0 | ||
264 | 0 | _c20150818 | |
008 | 201508s 0 0 eng d | ||
022 | _a1724-6040 | ||
024 | 7 |
_a10.5301/ijao.5000359 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFabrizi, Fabrizio | |
245 | 0 | 0 |
_aAcute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study. _h[electronic resource] |
260 |
_bThe International journal of artificial organs _cNov 2014 |
||
300 |
_a803-8 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAllografts |
650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xchemically induced |
650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xdiagnosis |
650 | 0 | 4 | _aReoperation |
650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTherapeutics |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aD'Ambrosio, Roberta | |
700 | 1 | _aPallotti, Francesco | |
700 | 1 | _aBerardinelli, Luisa | |
700 | 1 | _aMessa, Piergiorgio | |
700 | 1 | _aMartin, Paul | |
700 | 1 | _aAghemo, Alessio | |
773 | 0 |
_tThe International journal of artificial organs _gvol. 37 _gno. 11 _gp. 803-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5301/ijao.5000359 _zAvailable from publisher's website |
999 |
_c24322031 _d24322031 |